Voxelotor for Improving Oxygen Saturation in Adults

PHASE2TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

May 3, 2022

Primary Completion Date

June 28, 2023

Study Completion Date

July 4, 2023

Conditions
Acute Lung InjuryEnd Stage Lung Disease
Interventions
DRUG

Voxelotor

500 mg of voxelotor will be administered two times a day (for a total daily dose of 1000 mg per day) for 5 days. This dose may increase to a total maximum daily dose of 1500 mg (500 mg three times a day) if subject tolerates initial dose as determined by Principal Investigator (PI).

Trial Locations (1)

27710

Duke University Health System, Durham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Duke University

OTHER